Thermo-sensitive bone growth compositions
AssigneeGenzyme Corporation
InventorsKuber T. Sampath, Michael Philbrook, Aviva Shiedlin, John M. McPherson
Life of this patent
Estimating the term…
Loading patent…
AssigneeGenzyme Corporation
InventorsKuber T. Sampath, Michael Philbrook, Aviva Shiedlin, John M. McPherson
Estimating the term…
A non-invasive injectable composition that contains type I collagen, an osteogenic growth factor (OSF), such as a bone morphogenetic protein and a reverse thermo-sensitive biodegradable polymer such as Poloxamer 407 in an aqueous vehicle. The formulation can be administered non-invasively, e.g., by injection, thus circumventing limitations of many currently marketed bone-inducing products. The injectable osteogenic formulation effectively induces bone formation at the desired locale. This injectable suspension could be used with bioresorbable bone mineral composites (e.g., Hydroxyapatite, Tri-calcium phosphate) and/or glycosaminoglycans (e.g., Hyaluronic acid, Heparin sulfate) to mold as putty and/slab as bone graft substitute implants to induce new bone formation in fracture healing and spine fusion procedures.
An injectable composition comprising an osteogenic growth factor (OSF), a reverse thermo-sensitive biodegradable poloxamer, and type I collagen in an aqueous vehicle.
Dependencies are inferred from the claim text.